Differentiating COVID-associated myocarditis from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mounika Reddy Vadiyala, M.B.B.S.[2]
Overview
COVID-19-associated myocarditis must be differentiated from other causes of dyspnea and chest pain, elevated cardiac biomarkers, ventricular dysfunction such as including Acute Coronary Syndrome, Stress-induced cardiomyopathy (Takotsubo cardiomyopathy) and Heart failure.
Differential Diagnosis
COVID-19-associated myocarditis must be differentiated from other causes of dyspnea and chest pain, elevated cardiac biomarkers, ventricular dysfunction such as including acute coronary syndrome, stress-induced cardiomyopathy (takotsubo cardiomyopathy) and heart failure.
| Diseases | Symptoms | Physical Examination | Diagnostic tests | Other Findings | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dyspnea on Exertion | Chest Pain | Hemoptysis | Fever | Tachypnea | Tachycardia | Chest X-ray | ECG | Echocardiography | CT scan and CMR | ||
| COVID-19-associated myocarditis | β | β | – | β | β | β |
|
|
|
|
Increased cardiac troponin level |
| COVID-19-associated myocardial infarction | β | β | – | β(Low-grade) | β/- | β/- |
|
|
|
– |
Increased cardiac troponin levels |
| COVID-19-associated stress cardiomyopathy | β | β | – | – | β | β |
|
|
|
|
Increased cardiac troponin and pro-BNP level, transient increase in catecholamine levels. |
| COVID-19-associated heart failure | β | – | β | – | β | β |
|
|
|
|
Increased NT-proBNP and cardiac troponins levels |
| COVID-19-associated pneumonia | β | β (Pleuritic) | β | β (Usually high) | β | β |
|
– | Increased inflammatory markers, including ESR, hs-CRP | ||
| COVID-19-associated acute respiratory distress syndrome | β | – | β | β | β | β |
|
– |
|
– | |
| COVID-19-associated pulmonary embolism | β (Usually sudden-onset) | β (Pleuritic) | β (If massive PE) | β (Low-grade) | β | β |
|
|
|
| |
References
Β© 2026 MyEClinic β IFTM Institut fΓΌr Telematik in der Medizin GmbH
